Edge Rankings

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Adial Pharmaceuticals Stock Price, Quotes and Forecasts | NASDAQ:ADIL | Benzinga

Q: What sector and industry does Adial Pharmaceuticals (ADIL) operate in?

Adial Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Explore Adial Pharmaceuticals stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for ADIL.

Open	$0.23
Close	-
Volume / Avg.	2.24M / 861.37K
Day Range	$0.22 - $0.23
52 Wk Range	0.32 - 3.00
Market Cap	$2.04M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	16
Short Interest	1.56%
Days to Cover	1

Recent News

Why Lennar Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket

Avi Kapoor

EXCLUSIVE: Adial Pharmaceuticals Lead Candidate For Alcohol Use Disorder Advances Toward Phase 3 Trial

Adial refines Phase 3 plans for AD04 in Alcohol Use Disorder, focusing on genetic subgroups and leveraging Cytel's advanced trial design expertise.

Vandana Singh

EXCLUSIVE: Adial Pharmaceuticals Secures FDA End of Phase 2 Meeting Request To Discuss Upcoming Clinical Development Plan For Lead Program

FDA schedules End of Phase 2 meeting with Adial to discuss Phase 3 plans for AD04, its genetically targeted drug for Alcohol Use Disorder.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$0.23
Close	-
Volume / Avg.	2.24M / 861.37K
Day Range	$0.22 - $0.23
52 Wk Range	0.32 - 3.00
Market Cap	$2.04M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	16
Short Interest	1.56%
Days to Cover	1

About Adial Pharmaceuticals Inc

Sector

Health Care

Industry

Pharmaceuticals

Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescr...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Adial Pharmaceuticals (ADIL) stock?

You can purchase shares of Adial Pharmaceuticals (NASDAQ:ADIL) through any online brokerage.

View our list of the best stock brokerages

Who are Adial Pharmaceuticals (ADIL) competitors?

Other companies in Adial Pharmaceuticals’s space includes: NovaBay Pharmaceuticals (AMEX:NBY), Processa Pharmaceuticals (NASDAQ:PCSA), Titan Pharma (NASDAQ:TTNP), 60 Degrees (NASDAQ:SXTP) and Akanda (NASDAQ:AKAN).

What is the forecast, or price target, for Adial Pharmaceuticals (ADIL) stock?

Adial Pharmaceuticals has a consensus price target of $7.00.

What is the current price for Adial Pharmaceuticals (ADIL)?

The stock price for Adial Pharmaceuticals (NASDAQ: ADIL) is $0.2331 last updated June 17, 2025 at 9:36 AM EDT.

Does Adial Pharmaceuticals (ADIL) pay a dividend?

There are no upcoming dividends for Adial Pharmaceuticals.

When is Adial Pharmaceuticals (NASDAQ:ADIL) reporting earnings?

Adial Pharmaceuticals’s Q2 earnings are confirmed for Tuesday, August 12, 2025.

Is Adial Pharmaceuticals (ADIL) going to split?

There is no upcoming split for Adial Pharmaceuticals.

What sector and industry does Adial Pharmaceuticals (ADIL) operate in?

Adial Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Comments

Adial Pharmaceuticals Stock Price, Quotes and Forecasts

Adial Pharmaceuticals (ADIL) Forecast